Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of avatrombopag in chronic hepatitis C virus-related thrombocytopenia
2010-024479-20Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of avatrombopag in Thrombocytopenia (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Proportion of responders in Treatment Period A1. Started Aug 2011; status: completed.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on 2010-024479-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024479-20.